公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: A randomized Phase III study | Li J.; Xu R.; Qin S.; Liu T.; Pan H.; Xu J.; Bi F.; Lim R.; Zhang S.; Ba Y.; Bai Y.; Fan N.; Tsuji A.; KUN-HUEI YEH ; Ma B.; Wei V.; Shi D.; Magherini E.; Shen L. | Future Oncology | 21 | 16 | |
2017 | Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study | ANN-LII CHENG ; Cornelio G.; Shen L.; Price T.; Yang T.-S.; Chung I.J.; Dai G.-H.; Lin J.-K.; Sharma A.; KUN-HUEI YEH ; Ma B.; Zaatar A.; Guan Z.; Masood N.; Srimuninnimit V.; Yau T.; Gibbs P.; Wang X.; Doval D.C.; Oh S.-T.; Shim B.Y.; Gorospe C.; Wang H.-M.; Sirachainan E.; Hill A.; Suh K.W.; Beier F.; Chatterjee S.; Lim R. | Clinical Colorectal Cancer | 21 | 19 | |
2022 | Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients | Blanchard P.; Lee A.W.M.; Carmel A.; Wai Tong N.; Ma J.; Chan A.T.C.; Hong R.L.; Chen M.-Y.; Chen L.; Li W.-F.; Huang P.-Y.; Kwong D.L.W.; Poh S.S.X.; Ngan R.; Mai H.-Q.; Ollivier C.; Fountzilas G.; Zhang L.; Bourhis J.; Aupérin A.; Lacas B.; Pignon J.-P.; Benhamou E.; Chakrabandhu S.; TC Chan A.; Chen Q.-Y.; Chen Y.; Chappell R.J.; Choi H.; TT Chua D.; Lee Kiang Chua M.; Higgins J.; Hong M.-H.; RUEY-LONG HONG ; Pun Hui E.; Hsiao C.F.; Kam M.; Angeliki Koliou G.; LW Kwong D.; Lai S.-C.; On Lam K.; LeBlanc M.L.; WM Lee A.; Fun Victor Lee H.; Fei Li W.; Ma B.; Mo F.; Moon J.; Tong Ng W.; O'Sullivan B.; Petit C.; Pierre Pignon J.; Poh S.X.; Rücker G.; Sham J.; Lim Soong Y.; Sun Y.; Tan T.; Tang L.-Q.; Tung Y.; Wee J.; Wu X.; Xu T.; Zhang Y.; Zhu G.; on behalf of the MAC-NPC collaborative Group | Clinical and Translational Radiation Oncology | 17 | 18 | |
2017 | Nitrite accumulation in continuous-flow partial autotrophic denitrification reactor using sulfide as electron donor | Liu C.; Li W.; Li X.; Zhao D.; Ma B.; Wang Y.; Liu F.; Lee D.-J. | Bioresource Technology | 85 | 79 | |
2021 | Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium | Shimizu T.; Kim D.-W.; Loong H.H.; CHIA-CHI LIN ; Ng M.C.H.; Yamamoto N.; Ma B.; Tan D.S.W. | Asia-Pacific Journal of Clinical Oncology | 2 | 1 | |
2020 | Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts | Bang Y.-J.; Su W.-C.; Schuler M.; Nam D.-H.; Lim W.T.; Bauer T.M.; Azaro A.; Poon R.T.P.; Hong D.; CHIA-CHI LIN ; Akimov M.; Ghebremariam S.; Zhao S.; Giovannini M.; Ma B. | Cancer Science | 43 | 35 | |
2015 | Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: Pharmacokinetics and recommended phase 2 dose | Venkatakrishnan K.; Kim T.M.; CHIA-CHI LIN ; Thye L.S.; Chng W.J.; Ma B.; Chen M.H.; Zhou X.; Liu H.; Kelly V.; Kim W.S. | Investigational New Drugs | 26 | 27 | |
2019 | Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancer | Price T.; Shen L.; Ma B.; Esser R.; Chen W.; Gibbs P.; Lim R.; ANN-LII CHENG | Asia-Pacific Journal of Clinical Oncology | 4 | 4 | |
2015 | Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial | Li J.; Qin S.; Xu R.; Yau T.C.C.; Ma B.; Pan H.; Xu J.; Bai Y.; Chi Y.; Wang L.; KUN-HUEI YEH ; Bi F.; Cheng Y.; Le A.T.; Lin J.-K.; Liu T.; Ma D.; Kappeler C.; Kalmus J.; Kim T.W. | The Lancet Oncology | 597 | 536 | |
2016 | The role of autoinducer-2 in aerobic granulation using alternating feed loadings strategy | Sun S.; Liu X.; Ma B.; Wan C.; Lee D.-J. | Bioresource Technology | 37 | 29 | |
2016 | Understanding of aerobic granulation enhanced by starvation in the perspective of quorum sensing | Liu X.; Sun S.; Ma B.; Zhang C.; Wan C.; Lee D.-J. | Applied Microbiology and Biotechnology | 47 | 42 |